...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Key Players

Awaken Dormant DNA, Epigenetically
Rob Ranulph Jones
Sep 1, 2016 (Vol. 36, No. 15)

"....Key players in bromodomain epigenetics work, especially as it relates to advanced clinical research, are Resverlogix and Zenith Epigenetics...."

Share
New Message
Please login to post a reply